BioVoice News August 2016 Issue 4 Volume 1 | Page 38

tech talk us to develop an extended portfolio with 6 new offerings this year. Based on the insights, we were able to improvise our products as per the requirements of our customers. We got inputs that the product that was launched by us last year had long hold overtime of 13 days which was not required. In few cases, the electricity outage was only limited for few hours and thus the feature of longer holdover time won’t be required. The product was more expensive and fit for every location. The clients felt that the product was heavy and over-designed. This response helped us to devise products that are more compact and economical. And it was possible because of our long term expertise in the refrigeration. We could start re-engineering the whole product and come up with affordable product called Lite Series. We earlier launched it in Mumbai and now Delhi. 38 BioVoiceNews | August 2016 “ Our new medical refrigeration portfolio can reduce 30% of global vaccine wastage. This technology offers to hold the temperature precisely at 4 degrees Celsius for a longer period of time. Light series can holdover for 3 days as compared to the heavy series for 13 days. It just requires itself to recharge 2.5 hours of electricity every day. What are the benefits of the new technology? We have been able to adapt the technology without diluting its core benefits to suit specific storage requirements of health centres and hospitals, including a more affordable Lite series for urban and semi urban health facilities. The clients also include pharma companies and vaccine storage facilities. New product range has brought down the holdover time by 10 days and the cost by 50 percent. So I think it is now truly competitive, can fight global technologies on price and quality yet be highly affordable. Technology patented by The Sure Chill comes with an externally readable data logger which records upto 30 days’ temperature reading and offers five customizable temperature alarm settings. Our new medical refrigeration portfolio can reduce 30% of global vaccine wastage. This technology offers to hold the temperature precisely at 4 degrees Celsius for a longer period of time. Light series